Stockscreener 앱 받기
8.475
0.61%
-0.095
전일 마감가:
$8.57
열려 있는:
$8.69
하루 거래량:
32,113
Relative Volume:
0.46
시가총액:
$237.24M
수익:
$21.25M
순이익/손실:
$-16.05M
주가수익비율:
-13.89
EPS:
-0.61
순현금흐름:
$-17.14M
1주 성능:
-12.55%
1개월 성능:
-2.77%
6개월 성능:
+70.01%
1년 성능:
+92.71%
1일 변동 폭
$8.357
$8.79
1주일 범위
$8.357
$9.81
52주 변동 폭
$3.96
$9.92
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
명칭
Fennec Pharmaceuticals Inc
전화
(919) 636-4530
주소
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
FENC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
8.50 | 238.52M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.18 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.48 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.36 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
808.25 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-11-22 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | 개시 | CapitalOne | Overweight |
| 2022-08-08 | 재개 | Craig Hallum | Buy |
| 2020-06-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-10-11 | 개시 | Goldman | Buy |
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Is Fennec Pharmaceuticals Inc. stock ready for breakoutWeekly Risk Report & Free Verified High Yield Trade Plans - newser.com
Why analysts raise outlook for Fennec Pharmaceuticals Inc. (RV41) stock2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Can Fennec Pharmaceuticals Inc. stock withstand economic slowdown2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com
(FRX) Equity Market Report (FRX:CA) - news.stocktradersdaily.com
Can Fennec Pharmaceuticals Inc. stock deliver consistent earnings growthMarket Movement Recap & Verified Technical Signals - newser.com
Rostislav Christov Raykov Buys 4,609 Shares of Fennec Pharmaceuticals (TSE:FRX) Stock - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Director Chris Anigeron Rallis Sells 1,775 Shares - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$256,237.35 in Stock - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Insider Southpoint Capital Advisors Lp Sells 26,900 Shares - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$265,650.01 in Stock - MarketBeat
Analysts Set Adherex Technologies Inc. (NASDAQ:FENC) Price Target at $13.33 - Defense World
Long term hold vs stop loss in Fennec Pharmaceuticals Inc.Weekly Earnings Recap & Low Risk High Reward Ideas - newser.com
Fennec Pharmaceuticals (TSE:FRX) Shares Pass Above 50 Day Moving AverageHere's What Happened - MarketBeat
Southpoint sells Fennec Pharmaceuticals (FENC) shares worth $636k By Investing.com - Investing.com Canada
(FRX) Trading Report (FRX:CA) - news.stocktradersdaily.com
Is now a turning point for Fennec Pharmaceuticals Inc.July 2025 Update & Real-Time Chart Pattern Alerts - newser.com
Southpoint sells Fennec Pharmaceuticals (FENC) shares worth $636k - Investing.com
Fennec Pharmaceuticals Inc. stock trend forecast2025 Market Outlook & Stepwise Entry and Exit Trade Signals - newser.com
How Fennec Pharmaceuticals Inc. (RV41) stock benefits from digital adoptionJuly 2025 Opening Moves & Fast Gaining Stock Reports - newser.com
Will Fennec Pharmaceuticals Inc. stock recover after recent dropJuly 2025 Fed Impact & Smart Investment Allocation Tips - newser.com
Will Fennec Pharmaceuticals Inc. stock benefit from AI adoptionPortfolio Performance Summary & Smart Money Movement Tracker - newser.com
Can Fennec Pharmaceuticals Inc. stock hit analyst price targetsRate Cut & High Conviction Buy Zone Alerts - newser.com
Can Fennec Pharmaceuticals Inc. rally from current levelsJuly 2025 Movers & High Yield Equity Trading Tips - newser.com
Adherex Technologies (NASDAQ:FENC) Trading Down 1.4% After Insider Selling - Defense World
Learn to Evaluate (FRX) using the Charts (FRX:CA) - news.stocktradersdaily.com
What drives Fennec Pharmaceuticals Inc stock priceDividend Stability Analysis & Free Take Advantage Of Momentum - earlytimes.in
Fennec Pharmaceuticals (TSE:FRX) Reaches New 1-Year HighStill a Buy? - MarketBeat
Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares for $97,800 - Investing.com
What downside risks could hit Fennec Pharmaceuticals Inc. (RV41) stockPortfolio Performance Summary & Real-Time Sentiment Analysis - newser.com
Using AI based signals to follow Fennec Pharmaceuticals Inc.July 2025 Summary & Safe Capital Preservation Plans - newser.com
Is Fennec Pharmaceuticals Inc. stock positioned well for digital economy2025 Historical Comparison & Real-Time Stock Entry Alerts - newser.com
How buyback programs support Fennec Pharmaceuticals Inc. (RV41) stockWall Street Watch & Technical Entry and Exit Alerts - newser.com
(FRX) Equity Trading Insights (FRX:CA) - news.stocktradersdaily.com
Using Ichimoku Cloud for Fennec Pharmaceuticals Inc. technicalsOptions Play & High Accuracy Trade Signal Alerts - newser.com
Chart based analysis of Fennec Pharmaceuticals Inc. trendsQuarterly Portfolio Review & Risk Managed Investment Strategies - newser.com
Can Fennec Pharmaceuticals Inc. (RV41) stock sustain double digit ROEJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Fennec Pharmaceuticals Hits Day High with Strong 7.98% Intraday Surge - Markets Mojo
Fennec Pharmaceuticals (TSE:FRX) Reaches New 12-Month HighTime to Buy? - MarketBeat
Fennec Pharmaceuticals Inc (FENC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fennec Pharmaceuticals Inc 주식 (FENC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP | 10% Owner |
Oct 07 '25 |
Sale |
9.59 |
26,900 |
257,893 |
4,050,314 |
| Southpoint Capital Advisors LP | 10% Owner |
Oct 09 '25 |
Sale |
9.35 |
20,609 |
192,614 |
4,010,100 |
| Southpoint Capital Advisors LP | 10% Owner |
Oct 08 '25 |
Sale |
9.47 |
19,605 |
185,722 |
4,030,709 |
| Raykov Rosty | Director |
Oct 08 '25 |
Option Exercise |
2.45 |
4,609 |
11,292 |
87,110 |
| Raykov Rosty | Director |
Oct 06 '25 |
Sale |
9.78 |
10,000 |
97,800 |
82,501 |
0.86%
자본화:
|
볼륨(24시간):